↳ Index > Factsheets > Aniracetam
| Aniracetam | Info |
|---|
| Summary | An anxiolytic nootropic which modulates the AMPA receptor. Significantly more potent than racetam. May have positive effects on memory and cognition. Little recreational value. Sold in Europe as a prescription drug, but not approved by the FDA in the US. |
| Dose | Oral Common: 1500mg |
| Onset | Rapid |
| Duration | 2-4 hours. |
| Categories | research-chemical nootropic |
| Bioavaiability | Oral: 8.6-11.4% (This is due to the extensive first pass hepatic metabolism) Presumably higher when taken with fatty acids. |
| After-effects | 1-4 hours. |